This mother of two has ovarian cancer, and has been in palliative care since June. She's now telling her life story to a volunteer biographer so her young daughters can get to know her when she's gone.
Eloise Babos always wanted children but a genetic condition has sped up her plans and put her on track to remove her ovaries by her early 30s.
Thousands of women diagnosed with ovarian cancer will be tested to see if they are hidden carriers of BRCA gene mutations, which can cause the deadly disease.
The way we think about cancer is undergoing a slow but radical transformation, with studies at a molecular level revealing how "rare" each cancer is. How we fund research should change too, writes Darren Saunders.
The risk of insurance discrimination can deter families like mine from seeking critical information about their health, writes Krystal Barter.
People at high risk of developing breast and ovarian cancer will be offered free BRCA 1 and 2 genetic testing, with the Medical Services Advisory Committee deciding to list the test on the Medicare Benefits Schedule.
New research paints a clearer picture than ever before of the risk of breast cancer for carriers of the BRCA1, BRCA2 gene mutations and the need to identify carriers early on in life.